Cargando…

Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction

Improvement of risk scoring is particularly important for patients with preserved left ventricular ejection fraction (LVEF) who generally lack efficient monitoring of progressing heart failure. Here, we evaluated whether the combination of serum biomarkers and echocardiographic parameters may be use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pecherina, Tamara, Kutikhin, Anton, Kashtalap, Vasily, Karetnikova, Victoria, Gruzdeva, Olga, Hryachkova, Oksana, Barbarash, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278008/ https://www.ncbi.nlm.nih.gov/pubmed/32423119 http://dx.doi.org/10.3390/diagnostics10050301

Ejemplares similares

Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction
por: Karetnikova, Victoria, et al.
Publicado: (2016)

The Prognostic Value of Peripheral Artery Diseases in Patients with ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga L., et al.
Publicado: (2013)

Increased Serum Parathyroid Hormone, Osteocalcin and Alkaline Phosphatase Are Associated with a Long-Term Adverse Cardiovascular Outcome after Coronary Artery Bypass Graft Surgery
por: Barbarash, Olga, et al.
Publicado: (2019)

Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction
por: Osokina, Anastasia, et al.
Publicado: (2021)

Serum neutrophil gelatinase-associated lipocalin has an advantage over serum cystatin C and glomerular filtration rate in prediction of adverse cardiovascular outcome in patients with ST-segment elevation myocardial infarction
por: Barbarash, Olga L., et al.
Publicado: (2017)

Biological markers and cardiac remodelling following the myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Serum neutrophil gelatinase-associated lipocalin the estimation of hospital prognosis in patients with ST-elevated myocardial infarction
por: Karetnikova, Victoria, et al.
Publicado: (2017)

Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case–control study
por: Karetnikova, Victoria, et al.
Publicado: (2016)

Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure
por: Gruzdeva, Olga, et al.
Publicado: (2013)

Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga, et al.
Publicado: (2016)

Impact of recipient-related factors on structural dysfunction of xenoaortic bioprosthetic heart valves
por: Barbarash, Olga, et al.
Publicado: (2015)

Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2018)

Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
por: Belenkova, Yulia, et al.
Publicado: (2015)

Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction
por: Gruzdeva, Olga, et al.
Publicado: (2016)

Dose-dependent effects of atorvastatin on myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2015)

Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
por: Barbarash, Olga, et al.
Publicado: (2017)

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2017)

Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2014)

The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2016)

Relationship key factor of inflammation and the development of complications in the late period of myocardial infarction in patients with visceral obesity
por: Gruzdeva, Olga, et al.
Publicado: (2017)

Adipocytes Directly Affect Coronary Artery Disease Pathogenesis via Induction of Adipokine and Cytokine Imbalances
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Epigenetic remodeling in heart failure with preserved ejection fraction
por: Ambrosini, Samuele, et al.
Publicado: (2022)

Relationship between epicardial and perivascular fatty tissue and adipokine-cytokine level in coronary artery disease patients
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study
por: Cacciapuoti, Federico, et al.
Publicado: (2017)

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score
por: Huttin, Olivier, et al.
Publicado: (2021)

Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling
por: Stencel, Jason, et al.
Publicado: (2023)

Reverse electrical remodeling in rats with heart failure and preserved ejection fraction
por: Cho, Jae Hyung, et al.
Publicado: (2023)

Contributions of anemia to exercise intolerance in heart failure with preserved ejection fraction–An exercise stress echocardiographic study
por: Naito, Ayami, et al.
Publicado: (2023)

The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
por: Franssen, C., et al.
Publicado: (2016)

The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model
por: Cuijpers, Ilona, et al.
Publicado: (2020)

Visual echocardiographic scoring system of the left ventricular filling pressure and outcomes of heart failure with preserved ejection fraction
por: Murayama, Michito, et al.
Publicado: (2021)

Visual Estimation of Bedside Echocardiographic Ejection Fraction by Emergency Physicians
por: Ünlüer, Erden E., et al.
Publicado: (2014)

Cardiac steatosis and left ventricular remodeling in heart failure with reduced and preserved ejection fraction
por: Mahmod, Masliza, et al.
Publicado: (2015)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Fragmented QRS and subclinical left ventricular dysfunction in individuals with preserved ejection fraction: A speckle‐tracking echocardiographic study
por: Dehghani, Mohammad Reza, et al.
Publicado: (2019)

Clinical, Echocardiographic, and Therapeutic Characteristics of Heart Failure in Patients with Preserved, Mid-Range, and Reduced Ejection Fraction: Future Directions
por: Alem, Manal M
Publicado: (2021)

A Novel Three-Dimensional and Tissue Doppler Echocardiographic Index for Diagnosing and Prognosticating Heart Failure With Preserved Ejection Fraction
por: Wang, Weiding, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5nuf5fbv4ufsclm25je00hbfiv